Primitive reflexes (palmomental, snout, glabellar)
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Caudate atrophy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Memory Impairment, CTCAE 3.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Irritation - emotion
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Functional motor deficit
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral cortical atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Gait Disturbance, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Irritability, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Memory Impairment, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dementia
|
0.120 |
Biomarker
|
disease |
LHGDN |
A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features.
|
17708569 |
2007 |
Huntington Disease
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
The authors report a large series of patients with Huntington disease (HD)-like phenotype without CAG repeat expansions in the IT15 gene that were screened for the newly identified CAG/CTG expansion in the gene encoding junctophilin-3.
|
11914418 |
2002 |
Movement Disorders
|
0.010 |
Biomarker
|
group |
LHGDN |
A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features.
|
17708569 |
2007 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits.
|
28552196 |
2017 |
Serum gamma-glutamyl transferase measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
HUNTINGTON DISEASE-LIKE 2
|
0.800 |
Biomarker
|
disease |
CTD_human |
|
|
|
Colorectal Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.
|
17892325 |
2007 |
Colorectal Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.
|
17892325 |
2007 |
HUNTINGTON DISEASE-LIKE 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
HUNTINGTON DISEASE-LIKE 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Huntington's Disease Like-2 (HDL2) is a rare autosomal dominant genetic disease caused by a mutation in the JPH3 gene.
|
31704316 |
2020 |
HUNTINGTON DISEASE-LIKE 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The existence of a JPH3 splice variant with the CTG repeat in 3' untranslated region suggested that transcripts containing an expanded CUG repeat could play a role in the pathogenesis of HDL2, similar to the proposed pathogenic role of expanded CUG repeats in myotonic dystrophy type 1 (DM1).
|
17387722 |
2007 |
HUNTINGTON DISEASE-LIKE 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
<i>JPH3</i> mutations are linked to Huntington's disease-like 2 syndrome.
|
28656064 |
2017 |
HUNTINGTON DISEASE-LIKE 2
|
0.800 |
Biomarker
|
disease |
BEFREE |
Huntington disease-like 2 (HDL2) is a neurodegenerative disorder caused by an expansion of a CTG repeat in the junctophilin-3 gene (JPH3).
|
17708569 |
2007 |
HUNTINGTON DISEASE-LIKE 2
|
0.800 |
Biomarker
|
disease |
BEFREE |
Huntington's Disease-Like 2 (HDL2), caused by a CTG/CAG expansion in JPH3 on chromosome 16q24, is the most common Huntington's Disease (HD) phenocopy in populations with African ancestry.
|
30682531 |
2019 |
HUNTINGTON DISEASE-LIKE 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2.
|
11694876 |
2001 |
HUNTINGTON DISEASE-LIKE 2
|
0.800 |
Biomarker
|
disease |
BEFREE |
However, 15% (20/130) of black South African patients and no white patients (0/171) had an expansion in JPH3, confirming the diagnosis of Huntington disease like 2 (HDL2).
|
26079385 |
2015 |